αvβ3 and macrophage colony-stimulating factor: partners in osteoclast biology
Article first published online: 22 NOV 2005
Volume 208, Issue 1, pages 88–105, December 2005
How to Cite
Ross, F. P. and Teitelbaum, S. L. (2005), αvβ3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunological Reviews, 208: 88–105. doi: 10.1111/j.0105-2896.2005.00331.x
- Issue published online: 22 NOV 2005
- Article first published online: 22 NOV 2005
Summary: Osteoclasts, the sole bone-resorbing cells, arise by fusion and differentiation of monocyte/macrophage precursors. Matrix degradation requires adhesion of the osteoclast to bone, an integrin αvβ3-mediated event that also stimulates signals which polarize the cell and secrete resorptive molecules such as hydrochloric acid and acidic proteases. Two cytokines are necessary and sufficient for osteoclastogenesis, receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF), both produced by mesenchymal cells in the bone marrow environment. M-CSF promotes survival and proliferation of osteoclast precursors. It also contributes to their differentiation and regulates the cytoskeletal changes that accompany bone resorption. Binding of M-CSF to c-Fms, its receptor, recruits adapter proteins and cytosolic kinases, thereby activating a variety of intracellular signals. We herein review how αvβ3 and M-CSF, alone and in concert, impact production, survival, and function of the osteoclast, thereby controlling skeletal mass. Signals from αvβ3 and/or c-Fms activate Syk and Vav3, originally defined by their function in lymphoid cells. Genetic depletion of either protein generates a strong bone phenotype, underscoring the promise of osteoimmunobiology.